KCT0002029招募中未知
A randomized, multi-center, double-blinded, placebo controlled, investigator initiated trial to assess the impact on quality of life of L-carnitine administration in the liver cirrhosis due to chronic hepatitis B patients with Covert hepatic encephalopathy
Hanyang University Seoul Hospital0 个研究点目标入组 150 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 150
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional Study
入排标准
- 年龄范围
- 19(Year) 至 65(Year)（—）
- 性别
- All
入选标准
- •1. Age : 19-65 years old
- •2. Hepatitis B associated cirrhosis
- •3. Covert hepatic encephalopathy (Minimal hepatic HE or West Heaven Grade I )
- •4. Informed consent
排除标准
- •1. History of overt hepatic encephalopathy (West Heave grade II or more)
- •2. History of psychiatric or neurologic disease
- •3. Malignant tumor (except well controlled hepatocellular carcinoma)
- •4. Viable hepatocelluar carcinoma
- •5. Recent upper gastrointestinal bleeding within 6 months
- •6. Immune suppressive agent medication
- •7. ALT > 400 IU/L
- •8. Serum creatinin > 1.5 mg/dl
- •9. Hypersensitivity to carnitine
- •10. Significant alcohol consumption ( male > 210 g/week, female> 140 g/week)
- •11. Women who want to pregnant
- •12. Pregnant women
- •13. Join recent another clinical trial within 1 month.
研究者
相似试验
进行中（未招募）
不适用
A multi-center, blinded, randomized study to assess the safety, tolerability and efficacy of an application of DLX105 onto affected skin in comparison to placebo in patients with mild-to-moderate psoriasis vulgarismild-to-moderate plaque-type psoriasis vulgaris 6(PASI =15)MedDRA version: 16.0Level: LLTClassification code 10050576Term: Psoriasis vulgarisSystem Organ Class: 100000004858EUCTR2013-001885-41-ATDelenex Therapeutics AG54
招募中
1 期
A Study of Safety, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Ascending Oral Doses of VE-01902 in Healthy VolunteersCardiovascular - Coronary heart diseaseAtrial FibrillationACTRN12618001509257VCR1134
进行中（未招募）
不适用
A multi-center, blinded, randomized study to assess the safety, tolerability and efficacy of an application of DLX105 onto affected skin in comparison to placebo in patients with mild-to-moderate psoriasis vulgarismild-to-moderate plaque-type psoriasis vulgaris 6(PASI =15)MedDRA version: 17.1Level: LLTClassification code 10050576Term: Psoriasis vulgarisSystem Organ Class: 100000004858EUCTR2013-001885-41-DEDelenex Therapeutics AG54
招募中
不适用
The efficacy and safety of GI 7 in Subjects with irritable bowel syndromeKCT0001744Cell Biotech116
已完成
不适用
A multi-center, randomized, double-blinded, placebo-controlled, dose-exploratory, parallel Phase ?a clinical trial to evaluate the efficacy and safety by treating CU03-1001 Tablet for 12 weeks in patients with wet Age-related Macular DegeneratioKCT0004815Curacle75